Over the last 7 days, the United States market has risen by 2.0% and is up 12% over the past year, with earnings forecasted to grow by 14% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and robust financial health to capitalize on these favorable conditions.

Click here to see the full list of 230 stocks from our US High Growth Tech and AI Stocks screener.

We're going to check out a few of the best picks from our screener tool.

★★★★☆☆

AbbVie Inc. is a research-based biopharmaceutical company focused on the development, manufacture, and sale of medicines and therapies globally, with a market capitalization of approximately $328.75 billion.

AbbVie generates revenue primarily from its Innovative Medicines and Therapies segment, which accounts for $57.37 billion. The company is involved in the research, development, manufacture, and sale of biopharmaceutical products worldwide.

AbbVie's strategic alliance with the Sarah Cannon Research Institute, announced on May 28, 2025, underscores its commitment to accelerating cancer therapy innovations. This collaboration is expected to enhance clinical trial delivery and drug development efficiency through SCRI's advanced research capabilities. Concurrently, AbbVie's recent FDA approval of EMRELIS™ for specific lung cancer patients highlights its ongoing focus on addressing critical medical needs through targeted therapies. These developments reflect AbbVie’s robust investment in R&D which is integral to advancing its pipeline and maintaining competitive advantage in biotech innovation.

★★★★☆☆

Overview: Fair Isaac Corporation is a company that specializes in developing software with analytics and digital decisioning technologies for global markets, with a market cap of $42.02 billion.